Neoadjuvant chemotherapy group:None
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, the First Affiliated Hospital of University of Science and Technology of China, Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China, West China Hospital of Sichuan University, The First Affiliated Hospital of Chongqing Medical University
Conditions
Breast CancerLocally Advanced Gastric CancerLung cancerSmall cell lung cancerhigh grade serous ovarian cancerrectal cancer
Early Phase 1
Clinical study on screening and identification of tumor derived eccDNA for predicting HRD status of high-grade serous ovarian cancer (DAISY2)
Active, not recruitingChiCTR2200066898
Start: 2022-12-25Updated: 2023-05-15
Clinical study on prediction of minimal residual lesions (MRD) in high-grade serous ovarian cancer by extrachromosomal circular DNA (eccDNA) (DAISY1)
Active, not recruitingChiCTR2200066986
Start: 2022-12-25Updated: 2023-05-15
Unknown Phase
Comparison of curative effect between surgery after neoadjuvant chemotherapy and radical gastrectomy plus pancreaticoduodenectomy in locally advanced gastric cancer
Active, not recruitingChiCTR2200063959
Start: 2022-10-01Updated: 2023-04-17
Effect of neoadjuvant chemotherapy versus chemoradiation on anorectal function and quality of life of patients underwent laparoscopic inter- sphincter resection: A prospective observational study
RecruitingChiCTR2300069083
Start: 2022-09-10Updated: 2023-05-22
Long-term survival outcomes in patients with HR+/Her2-, stage IIA-IIIA breast cancer treated with adjuvant chemotherapy versus neoadjuvant chemotherapy: a real-world study
Active, not recruitingChiCTR2400083063
Start: 2024-04-15Updated: 2024-04-22
Cost-effectiveness analysis of neoadjuvant chemotherapy versus adjuvant chemotherapy with advanced non-small cell lung cancer during intial treatment phase in real-word setting
Active, not recruitingChiCTR2500097471
Start: 2024-03-01Updated: 2025-02-24
Efficacy of the combination of immune checkpoint inhibitors and chemotherapy compared with chemotherapy alone in neoadjuvant treatment of stage I-III small cell lung cancer and exploration of biomarkers
Active, not recruitingChiCTR2500104328
Start: 2025-06-20Updated: 2025-06-24